ÐÂÎÅ×ÊѶ
ÈçºÎÈÃÍâÃÚÌå»úÖÆÑо¿¡°¼ò¶ø²»Ê§Æ仪¡±£¿
- ·ÖÀࣺ»ªÓ¯ÊÓ½Ç
- ×÷ÕߣºÈðÈð
- À´Ô´£ºk8¿·¢(Öйú)¹«ÖÚºÅ
¡¾¸ÅÒªÃèÊö¡¿ÍâÃÚÌå»úÖÆÑо¿ÖÐÈçºÎÓ¦ÓÃ×éѧ¼¼Êõ¼°¶à×éѧÁªºÏ·ÖÎö£¿
ÈçºÎÈÃÍâÃÚÌå»úÖÆÑо¿¡°¼ò¶ø²»Ê§Æ仪¡±£¿
¡¾¸ÅÒªÃèÊö¡¿ÍâÃÚÌå»úÖÆÑо¿ÖÐÈçºÎÓ¦ÓÃ×éѧ¼¼Êõ¼°¶à×éѧÁªºÏ·ÖÎö£¿
- ·ÖÀࣺ»ªÓ¯ÊÓ½Ç
- ×÷ÕߣºÈðÈð
- À´Ô´£ºk8¿·¢(Öйú)¹«ÖÚºÅ
- ·¢²¼Ê±¼ä£º2021-12-29 15:24
- ·ÃÎÊÁ¿£º
ÍâÃÚÌåµÄ»úÖÆÑо¿Éæ¼°µ½¶à¸ö²ã´ÎºÍ¶à·½Ãæ¿ÆѧÎÊÌâµÄ̽¾¿¡£ÆðÓÚÍâÃÚÌåµÄÉúÎïѧ×÷ÓõÄ֤ʵ£¬½ø¶ø·ÖÎöÍâÃÚÌåÈçºÎ·¢»Ó×÷Óã¬Ç°ÕßÖ÷ÒªÊDZíÐ͵ķÖÎö£¬ºóÕß°üÀ¨ÁËÍâÃÚÌåÓ°ÏìµÄ·Ö×Ó²ãÃæµÄ±ä»¯¼°ÍâÃÚÌåÖÐÖ´Ðй¦ÄܵĹؼüÔªËØÊÇʲô¡£×éѧ¼¼ÊõµÄ½éÈëÒÑȻΪÎÒÃÇÑо¿ÍâÃÚÌåÔõÑù·¢»Ó×÷ÓÃÌṩÁËÒ»ÖÖÊ°빦±¶µÄ²ßÂÔ¡£
ÄÇôÍâÃÚÌå»úÖÆÑо¿ÖÐÈçºÎÓ¦ÓÃ×éѧ¼¼Êõ¼°¶à×éѧÁªºÏ·ÖÎö£¿Æä·ÖÎöÊÇ·ñ·Ç³£¸´ÔÓ£¿»ªÓ¯ÊӽǾÍΪ´ó¼Ò·ÖÏí¼¸ÆªÍâÃÚÌå»úÖÆÑо¿ÖÐ×éѧ¼°¶à×éѧÁªºÏÓ¦ÓõݸÀý£¬»òÐíÄÜΪ´ó¼ÒµÄÑо¿ÌṩеÄ˼·¡£
| °¸ÀýÒ»:¶à×éѧÁªºÏ·ÖÎöÐļ¡Çòϸ°ûÀ´Ô´µÄÍâÃÚÌå´¦ÀíÐÄÂÉʧ³£ÐÔÐļ¡Ñ×µÄ×÷ÓûúÖÆ
ÐÄÂÉʧ³£ÐÔÐļ¡Ñ×£¨ACM£©ÊÇÒ»ÖÖÒÅ´«ÐÔÐÄÔ༲²¡£¬Ñо¿ÈËԱͨ¹ý¶à×éѧÁªºÏ·ÖÎöÁËÓÀÉú»¯Ðļ¡Çòϸ°ûÀ´Ô´µÄÍâÃÚÌåÔÚACMÄ£ÐÍDsg2Í»±äСÊóÖеÄ×÷Óü°»úÖÆ£¬Ïà¹Ø³É¹û½üÆÚ·¢±íÓÚÐÄÔàÁìÓòµÄ¶¥¼¶ÆÚ¿¯European Heart Journal£¨IF: 29.983£©1¡£Ñо¿ÈËÔ±ÔÚÍ»±äÊó4ÖÜÁäʱ¿ªÊ¼Î²¾²Âö×¢ÉäÍâÃÚÌ壬·¢ÏÖÁËÐļ¡Çòϸ°ûÀ´Ô´µÄÍâÃÚÌå¿ÉÒÔ¸ÄÉÆÍ»±äÊóÐÄÊÒ¹¦Äܼ°½á¹¹¡¢¼õÉÙÏËά»¯ºÍÐÄÂÉʧ³£µÈ£¨Í¼1£©¡£
ͼ1£ºÊÕ¼¯Ðļ¡Çòϸ°ûÀ´Ô´µÄÍâÃÚÌåºÍ´¦ÀíÍ»±äСÊó
ÒòΪÑ×Ö¢Ïà¹ØÐźÅÔÚACMµÄ½øÕ¹ÖÐÆ𵽷dz£ÖØÒªµÄ×÷Óã¬Ñо¿ÈËÔ±Ê×ÏÈͨ¹ýת¼×éѧ·ÖÎöÁËÍâÃÚÌå´¦ÀíµÄÍ»±äÊ󡢶ÔÕÕ´¦ÀíµÄÍ»±äÊóºÍÒ°ÉúÐÍСÊóÐÄÔà×éÖ¯µÄ»ùÒò±í´ï£¬½á¹û·¢ÏÖÁËÍâÃÚÌå¿ÉÒÔ“¾ÀÕý”Í»±äÊóÐÄÔàÖкܶàÑ×Ö¢»ùÒòµÄÒì³£±í´ï£¨Í¼2A£©¡£Ñ×Ö¢Òò×Óת¼ˮƽ·¢Éú±ä»¯£¬ÄÇôµ°°×ˮƽÊÇ·ñÒ²·¢ÉúÁ˱仯£¿ÓÚÊÇÑо¿ÈËÔ±²ÉÓÃÁË¿¹ÌåоƬµÄ·½·¨¼ì²âÉÏÊöÈý×éСÊóÐÄÔàµÄÏà¹Øϸ°ûÒò×ӵı仯¡£½á¹û·¢ÏÖÁ˺ÍÒ°ÉúÐÍСÊóÏà±È£¬Í»±äÊóÖжàÖÖϸ°ûÒò×ӵıí´ïÏÔÖøÔö¼Ó£¬µ«ÊÇÍâÃÚÌå´¦Àí»áÏÔÖø½µµÍÍ»±äÊóÖÐÕâЩϸ°ûÒò×ӵıí´ï£¨Í¼2B£©£¬ËµÃ÷ÍâÃÚÌå´¦Àí¿ÉÒÔ»º½âACMÖеÄÑ×Ö¢·´Ó¦¡£
ͼ2£ºÍâÃÚÌå¸Ä±äÍ»±äÊóÐÄÔà×éÖ¯µÄ»ùÒòºÍϸ°ûÒò×Ó±í´ï
ת¼×éºÍϸ°ûÒò×Ó¿¹ÌåоƬµÄ½á¹û¶¼·¢ÏÖÁËNF-κBͨ·µÄ·Ö×ÓÔÚÍ»±äÊóÖÐÏÔÖøÉϵ÷£¬ÕâЩ½á¹ûÓëNF-κB¿ÉÒÔ´Ù½øÑ×Ö¢·´Ó¦ºÍÐļ¡Ï¸°ûËÀÍöµÄÖØÒª×÷ÓÃÏàÒ»Ö¡£Ñо¿ÈËÔ±¼Ì¶øÑéÖ¤ÁËÍâÃÚÌåµÄÈ·¿ÉÒÔ¼õÈõNF-κBÐźÅͨ·µÄ»îÐÔ£¨Í¼3A£©¡£ÄÇôÍâÃÚÌåµ÷¿ØÐļ¡Ï¸°ûNF-κBÐźÅͨ·µÄ»úÖƺ͹¦ÄÜ·Ö×ÓÊÇʲô£¿ÒòΪÑо¿µÄÊÇÓÀÉú»¯Ï¸°û£¬ËùÒÔÔ´úÐļ¡Çòϸ°ûÓÃ×÷¶ÔÕÕ£¬Ñо¿ÈËÔ±¶ÔÁ½ÖÖÐļ¡Çòϸ°ûÀ´Ô´µÄÍâÃÚÌ忪չÁËsmall-RNA²âÐò£¬×ܹ²¼ø¶¨ÁË850¶à¸ömiRNA¡£ÆäÖбí´ï·á¶È×î¸ßµÄÇ°21¸ömiRNAͨ¹ýIngenuity Pathway Analysis £¨IPA£©·ÖÎö·¢ÏÖÁ˺ܶ඼ÓëNF-κBͨ·Ïà¹Ø£¨Í¼3B£©£¬ÆäÖÐÓÐ6¸ömiRNAÔÚÓÀÉú»¯Ðļ¡Çòϸ°ûÀ´Ô´µÄÍâÃÚÌåÖÐÏÔÖøÉϵ÷£¬ÓÚÊÇÑо¿ÈËÔ±ÓÃÍâÃÚÌå´¦ÀíÇýµÁË6¸ömiRNA±í´ïµÄÐÂÉú´óÊóÐÄÊÒ¼¡Ï¸°û£¬½á¹û·¢ÏÖÖ»ÓÐȱʧmiR-4488¿ÉÒÔµ¼ÖÂÍâÃÚÌå¶ÔNF-kBͨ·µÄ¼õÈõЧ¹ûÏûʧ£¨Í¼3C£©£¬ËµÃ÷ÍâÃÚÌåͨ¹ýÆ京ÓеÄmiR-4488·¢»Ó×÷Óã¬×îºóÌåÄÚʵÑéÒ²Ö¤Ã÷ÁËͬʱÔÚÍ»±äÊóÖÐ×¢ÉäÍâÃÚÌåºÍ¸ÉÈÅmiR-4488 RNAºó£¬ÍâÃÚÌåʧȥÁËÖÎÁÆ×÷Óã¨Í¼3D£©¡£
ͼ3£ºÍâÃÚÌåÖÎÁÆACMµÄ×÷ÓûúÖÆ
Ñо¿ÈËÔ±Ò²¶ÔÍâÃÚÌå½øÐÐÁ˵°°×ÖÊ×éѧµÄ·ÖÎö£¬¼ø¶¨Á˺ܶàÔÚÓÀÉú»¯Ðļ¡Çòϸ°ûÀ´Ô´µÄÍâÃÚÌåÖи߱í´ï¼°ÌØÓеĵ°°×£¨Í¼4£©¡£GO·ÖÎö·¢ÏÖÕâЩµ°°×Óëϸ°ûÉú³¤¡¢ÄÜÁ¿´úлºÍÐźÅתµ¼Ïà¹Ø£¬ÍƲâÍâÃÚÌå´«µÝÕâЩµ°°×µ½Ðļ¡Ï¸°û¿ÉÒÔ±ãÓÚÐļ¡ÐÞ¸´£¬Ò²ÎªºóÐø¼ø¶¨ÍâÃÚÌåÖйؼüµ°°×·Ö×ӵ춨ÁËÇ°ÆÚ»ù´¡¡£
ͼ4£ºÍâÃÚÌåµ°°×ÖÊ×éѧ·ÖÎö
| °¸Àý¶þ:µ°°×ÖÊ×éѧӦÓÃÓÚÑÌÎí²¡Ïà¹ØµÄÍâÃÚÌåÑо¿ÖÐ
ÑÌÎí²¡ÊÇÒ»ÖÖ²¡Òò²»Ã÷¡¢´óÄÔѪ¹ÜÂýÐÔ½øÐÐÐÔÏÁÕ»ò±ÕÈûΪÌØÕ÷£¬²¢¼Ì·¢Âµ×Ò쳣Ѫ¹ÜÍøÐγɵÄÄÔѪ¹Ü¼²²¡¡£½üÆÚÀ´×Ô½â·Å¾ü×ÜÒ½ÔºµÚÎåҽѧÖÐÐĺͱ±¾©ÐºÍҽѧԺµÄÑо¿ÈËÔ±¶ÔÑÌÎí²¡²¡ÈËѪÇåÍâÃÚÌ忪չÁ˹¦ÄÜÑо¿£¬Ïà¹Ø³É¹û·¢±íÓÚ¸ÃÁìÓòȨÍþÆÚ¿¯Stroke£¨IF: 7.914£©2¡£Ñо¿ÕßÄÉÈëÁË132¸öÑÌÎí²¡²¡ÈË°üÀ¨77¸öȱѪÐÔ²¡ÈË£¨ischemic£©ºÍ55¸ö³öѪÐÔ²¡ÈË£¨hemorrhagic£©£¬ÒÔ¼°22¸ö½¡¿µ¶ÔÕÕ¡£Ñо¿ÈËÔ±¶ÔѪÇåÀ´Ô´µÄÍâÃÚÌ忪չÁËTMTµ°°×ÖÊ×éѧ·ÖÎöºÍϸ°û¹¦ÄÜʵÑ飨ͼ5£©¡£
ͼ5£ºÑÌÎí²¡ÑªÇåÍâÃÚÌ幦ÄÜʵÑé¼°µ°°×ÖÊѧ·ÖÎö
qEV»òÕßTEIÊÔ¼ÁºÐÊÕ¼¯µÄѪÇåÍâÃÚÌ忪չϸ°û¹¦ÄÜʵÑ飬½á¹û·¢ÏÖÑÌÎí²¡ÈËѪÇåÀ´Ô´µÄÍâÃÚÌå¿ÉÒÔÏÔÖø´Ù½øСÊóÄÔѪ¹ÜÄÚƤϸ°ûµÄÔöÖ³£¬³öѪÐÔÑÌÎí²¡ÈËѪÇåÍâÃÚÌ壨Hemo£©µÄ×÷ÓÃЧ¹û×îÏÔÖø¡£ÎªÁ˽âÊÍÍâÃÚÌå¶ÔÄÔѪ¹ÜÄÚƤϸ°ûµÄ×÷ÓûúÖÆ£¬Ñо¿Õ߶ÔÍâÃÚÌå´¦ÀíµÄϸ°û¿ªÕ¹ÁËTMTµ°°×ÖÊ×éѧ·ÖÎö¡£Ï¸°ûµÄTMTµ°°×ÖÊ×é×ܹ²¼ø¶¨ÁË6516¸öµ°°×£¨unique peptides≥2£©£¬Ïà±ÈÆäËûÁ½×飬ÔÚ³öѪÐÔѪÇåÍâÃÚÌå´¦ÀíµÄϸ°ûÖмø¶¨ÁË17¸öϵ÷µÄµ°°×£¨Cluster 1£©ºÍ32¸öÉϵ÷µÄµ°°×£¨Cluster 2£©£¨Í¼6A£©¡£GOºÍWikiPathway¸»¼¯·ÖÎö·¢ÏÖÁËÕâЩ²îÒìµ°°×´ó¶àÊôÓÚÏßÁ£Ìå¼°Ïà¹ØµÄ³É·Ö£¨Í¼6B¡¢C£©¡£ÓÉ´Ë¿ÉÍƲâ³öѪÐÔÑÌÎí²¡ÈËѪÇåÀ´Ô´µÄÍâÃÚÌåÖ÷Ҫͨ¹ýÓ°ÏìÄÔѪ¹ÜÄÚƤϸ°ûµÄÏßÁ£Ì幦ÄÜÐõÂÒ·¢»Ó×÷Óã¬ÎªºóÐøÔÙ¿ªÕ¹ÉîÈëµÄ»úÖÆÑо¿Ëø¶¨ÁËDZÔÚµÄ×÷Óðе㡣
ͼ6£ºTMTµ°°×ÖÊ×éѧ·ÖÎöÍâÃÚÌå´¦ÀíµÄÄÔѪ¹ÜÄÚƤϸ°û
ÑÌÎí²¡²¡ÈËѪÇåÍâÃÚÌåÉÏÊö×÷ÓõŦÄÜ·Ö×ÓÊÇʲô£¿Ñо¿ÈËÔ±¶Ô³¬ÀëÊÕ¼¯µÄÕý³£¡¢È±ÑªÐԺͳöѪÐÔÑÌÎí²¡ÈËѪÇåÍâÃÚÌå½øÐÐÁËÁ½×éÖظ´µÄTMTµ°°××éʵÑ飨ͼ5£©£¬Á½×é·Ö±ð¼ø¶¨ÁË890¸öºÍ1128¸öѪÇåÍâÃÚÌåµ°°×£¨unique peptides≥2£©£¬ÆäÖÐÁ½×éʵÑ鹲ͬ¼ø¶¨µ½ÁË859¸öÍâÃÚÌåµ°°×¡£ÓëÕý³£ÑªÇåÍâÃÚÌå¶Ô±È£¬È±ÑªºÍ³öѪÑÌÎí²¡ÈËѪÇåÍâÃÚÌå¹²ÓÐ231¸ö²îÒìµ°°×¡£GO·ÖÎöÕâЩÉÏÊö²îÒìµ°°×·¢ÏÖÁË24.8%£¨57¸ö£©µÄµ°°×Óëϸ°ûÉú³¤¼°Î¬³ÖÓйأ¬±Ë´Ë¼ä¿ÉÒÔÐγɽôÃܵĻ¥×÷ÍøÂ磨ͼ7£©£¬ÓÉ´Ë¿ÉÍƲâÑÌÎí²¡ÈËѪÇåÍâÃÚÌåµ÷¿ØÄÔѪ¹ÜÄÚƤϸ°ûÔöÖ³µÈЧ¹û»òÐíͨ¹ý´«µÝÕâЩͨ·µ°°×·¢»ÓÆä×÷Óá£
ͼ7£ºÍâÃÚÌåµ°°×ÖÊ×éѧ·ÖÎö
| °¸ÀýÈý:¶à×éѧ·ÖÎöÕæ¾ú¸ÐȾµÄ¾ÞÊÉϸ°ûÀ´Ô´µÄÍâÃÚÌåµÄ¹¦ÄܳɷÖ
ÐÂÉúÒþÇò¾ú£¨Cryptoccus neoformans£©ÔÚÃâÒßÁ¦µÍϵÄÈËȺÖлáÒýÆð·ÎºÍÄÔÑǼ±ÐÔ»òÂýÐÔ¸ÐȾ¡£À´×ÔÉϺ£³¤Õ÷Ò½ÔºÁªºÏ¹úÄÚÍâ¶à¼Ò¿ÆÑлú¹¹µÄÑо¿ÈËԱͨ¹ý¶à×éѧÁªºÏ·ÖÎöÁËÐÂÉúÒþÇò¾ú¸ÐȾµÄ¾ÞÊÉϸ°ûÊͷŵÄÍâÃÚÌåµÄ¹¦ÄÜ×é·Ö£¬Ïà¹Ø³É¹û½üÆÚ·¢±íÓÚ¸ÃÁìÓòµÄȨÍþÆÚ¿¯mBio£¨IF: 7.867£©3¡£Ñо¿ÈËÔ±Ê×ÏÈÊÕ¼¯ÁËÕý³£Ð¡Êó¹ÇËèÀ´Ô´µÄ¾ÞÊÉϸ°û£¨BMDM£©¡¢Ãð»î¾ú¸ÐȾµÄBMDMϸ°ûÒÔ¼°»î¾ú¸ÐȾµÄBMDMϸ°û·ÖÃÚµÄÍâÃÚÌ壬¶Ô±È·ÖÎöÕý³£BMDMϸ°ûÔÚ±»ÉÏÊöÈýÀàÍâÃÚÌå´¦ÀíºóµÄ¿¹Õæ¾ú»îÐÔ£¬½á¹û·¢ÏÖÁËÔÚ»î¾ú¸ÐȾÀ´Ô´µÄÍâÃÚÌå´¦ÀíÖ®ºó¾ßÓиüÏÔÖøµÄ¿¹Õæ¾úÄÜÁ¦£¨Í¼8 A£©¡£ÎªÁ˽ÒʾÕý³£¾ÞÊÉϸ°ûÔÚÊܵ½ÍâÃÚÌå´¦Àíºó·Ö×Ó²ãÃæµÄ¸Ä±ä£¬Ñо¿ÈËԱͨ¹ýת¼×éѧ·ÖÎöÁËÍâÃÚÌå´¦ÀíºÍ²»´¦ÀíµÄСÊóBMDMϸ°û¼°ÈËÍâÖÜѪÀ´Ô´µÄ¾ÞÊÉϸ°û£¨MDM£©µÄ²îÒì»ùÒò±í´ï£¨Í¼8 B£©£¬GO·ÖÎö·¢ÏÖÁËÁ½Ààϸ°ûµÄ²îÒì»ùÒòºÜ¶à¶¼ºÍϸ°ûÖÜÆںͷÖÁÑÏà¹Ø£¬ËµÃ÷ÁËÕæ¾ú¸ÐȾµÄ¾ÞÊÉϸ°ûÀ´Ô´µÄÍâÃÚÌå¿ÉÄÜͨ¹ýÓ°ÏìÕý³£¾ÞÊÉϸ°ûµÄϸ°ûÖÜÆÚÏà¹Øͨ··¢»Ó×÷Óá£
ͼ8£º×ªÂ¼×é·ÖÎöÍâÃÚÌå´¦ÀíµÄ¾ÞÊÉϸ°û
ΪÁ˶ԱÈÉÏÊö²»Í¬´¦ÀíBMDMϸ°ûÀ´Ô´µÄÍâÃÚÌåÖгɷֲîÒìÐÔ£¬Ñо¿ÈËÔ±¶ÔÉÏÊöÈýÖÖÀ´Ô´µÄÍâÃÚÌ忪չÁ˵°°×ÖÊ×éѧ¡¢Ö¬ÖÊ×éѧºÍ´úл×éѧµÄ·ÖÎö£¬×ܹ²¼ø¶¨ÁË1481¸öµ°°×£¬226¸öÖ¬ÀàºÍ59¸ö´úл²úÎï¡£µ°°×ÖÊ×éѧ·ÖÎö¼ø¶¨ÁËÈý×éÖ®¼äÓÐ46¸ö²îÒìµ°°×£¨Í¼9 A£©¡£Ö¬ÖÊ×éѧ·ÖÎö·¢ÏÖÁË×îÏÔÖø²îÒìµÄÖ¬Àà°üÀ¨Á×Ö¬õ£µ¨¼î£¨PC£©¡¢Á×Ö¬õ£ÒÒ´¼°·£¨PE£©ºÍÇÊÁ×Ö¬£¨SM£©£¨Í¼9 B£©¡£´úл×éѧ·ÖÎöÈ´·¢ÏÖ¸÷×éÖ®¼äÍâÃÚÌåÖв¢Ã»ÓÐÏÔÖø²îÒìµÄ´úлÎÕâЩ½á¹û±íÃ÷ÁËÐÂÉúÒþÇò¾ú¸ÐȾµÄ¾ÞÊÉϸ°ûÀ´Ô´µÄÍâÃÚÌå·¢»ÓÆä×÷ÓÿÉÄÜÖ÷ÒªÒÀÀµÓÚÍâÃÚÌåÔØÓеĵ°°×»òÕßÖ¬ÖʵķÖ×Ó¹¦ÄÜ¡£
ͼ9£ºÍâÃÚÌåµ°°×ÖÊ×éºÍÖ¬ÖÊ×éѧ·ÖÎö
´ÓÉÏÊöµÄÑо¿°¸ÀýÎÒÃÇ¿ÉÒÔ¿´µ½£¬ÍâÃÚÌå»úÖÆÑо¿ÖеÄ×éѧ·ÖÎö²¢²»¸´ÔÓ£¬·´¶øÈÃÎÒÃǵĻúÖÆÑо¿±äµÃ¼òÔ¼µ«²»¼òµ¥¡£×éѧ¼¼ÊõÖ÷ÒªÉæ¼°µ½ÆäÖÐÁ½´¦¹Ø¼ü¿ÆѧÎÊÌâµÄ½â¾ö£¬µÚÒ»¸öÊÇÍâÃÚÌå¶ÔÊÜÌå×éÖ¯/ϸ°û·Ö×Ó²ãÃæµÄÓ°Ï죬ÕâÊǽâÊͼ²²¡ÏÖÏó×îÖØÒªµÄDZÔÚ»úÖÆ£¬ÀýÈçÕâЩ°¸Àý²ÉÓÃÁËת¼×éѧ¡¢µ°°×ÖÊ×éѧ¼°¿¹ÌåоƬµÈ¸ßͨÁ¿µÄɸѡ·½·¨È¥Ëø¶¨Ä³Ð©Í¨Â·»òÕß²îÒìµ°°×µÄ¹¦Äܱ仯£»µÚ¶þ¸öÊÇ̽¾¿ÍâÃÚÌåÖÐÄÄЩԪËØÆðµ½ÖØÒª×÷Óã¬ÕâÊÇÌáÉýÍâÃÚÌå»úÖÆÑо¿Éî¶ÈºÍµµ´ÎµÄ¹Ø¼ü»·½Ú£¬¶àÖÖ×éѧ¶¼¿ÉÒÔ³¢ÊÔ±»ÓÃÀ´É¸Ñ¡ÍâÃÚÌåµÄ¹¦ÄÜ·Ö×Ó¡£×îÖØÒªµÄÊÇÍâÃÚÌå×éѧºÍÊÜÌåϸ°û×éѧ¼ä¿ÉÒԱ˴˺ôÓ¦£¬ÀýÈçµÚÒ»¸ö°¸ÀýÖÐÐÄÔà×é֯ϸ°ûÒò×ÓɸѡºÍÍâÃÚÌåÖÐmiRNA×éѧ½øÐÐÁËÁªºÏ·ÖÎö£¬·¢ÏÖÁËÍâÃÚÌåÖаÐÏòNF-κBͨ·µÄ¹Ø¼ü¹¦ÄÜ·Ö×ÓmiR-4488£¬Ñо¿Éî¶ÈËæ¼´¼ÓÉÀíËùµ±È»¿ÉÒÔ·¢µ½¸ü¸ß·ÖµÄÆÚ¿¯¡£×éѧ·ÖÎöÒ²¿ÉÒÔÆðµ½³ÐÇ°ÆôºóµÄ×÷Óã¬ÀýÈçºóÁ½¸ö°¸Àýͨ¹ý×éѧ·ÖÎö·¢ÏÖÁËÊÜÌåϸ°ûºÍÍâÃÚÌåÖкܶà¹Ø¼üµÄͨ·ºÍµ°°×£¬ÎªÖ®ºóÔÙ¼ÌÐøÉîÈëÑо¿ÌṩÁ˱¦¹óÊý¾Ý¡£
| ¹ØÓÚk8¿·¢(Öйú)
k8¿·¢(Öйú)×÷ΪÍâÃÚÌå·þÎñÁìÓòµÄר¼Ò£¬ÓµÓжÀÌصÄϵͳÐÔ·þÎñÓÅÊÆ£¬¿ÉʵÏÖÍâÃÚÌåÑо¿µÄ“һվʽ·þÎñ”¡£k8¿·¢(Öйú)µÄÍâÃÚÌå·þÎñ²úÆ·Ò²»ù±¾À©Õ¹µ½ÁËÍâÃÚÌåÑо¿µÄ·½·½ÃæÃ棬°üÀ¨£ºÍâÃÚÌåµÄÈýÏî¼ø¶¨£¨µç¾µ¡¢WB¡¢NTA£©¡¢ÍâÃÚÌåµ°°××éɸѡ£¨lable free¡¢DIA¡¢PRM¡¢MRM£©¡¢ÍâÃÚÌåºËËáɸѡ£¨miRNA¡¢RNAȫת¼×飩¡¢ÍâÃÚÌåÄÉÃ×Á÷ʽ¼ì²â¡¢ÍâÃÚÌåµçת£¨Ò©Îï·Ö×Ó¡¢ºËËᣩ¡¢ÍâÃÚÌåϸ°û&¶¯Î﹦ÄÜʵÑ飨PKH26/DiR/Á¿×ӵ㡢ӫ¹âʾ×Ù£©µÈ¡£
·á¸»È«ÃæµÄÍâÃÚÌ幦ÄÜÑо¿ÊÖ¶ÎÈ«¶¼ÔÚk8¿·¢(Öйú)µÄÎäÆ÷¿â£¨ÏÂͼ±êºìɫΪk8¿·¢(Öйú)ÌØÉ«·þÎñ£©ÖУ¬»¹²»¿ìÀ´pick£¿¨‹
| Ïà¹ØÎÄÏ×
[1]. Lin YN, Mesquita T, Sanchez L, Chen YH, Liu W, Li C et al. Extracellular vesicles from immortalized cardiosphere-derived cells attenuate arrhythmogenic cardiomyopathy in desmoglein-2 mutant mice. [J]. Eur Heart J. 2021:ehab419.
[2]. Wang X, Han C, Jia Y, Wang J, Ge W, Duan L. Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells. [J]. Stroke. 2021:STROKEAHA120032297.
[3]. Zhang L, Zhang K, Li H, Coelho C, de Souza Gonçalves D, Fu MS et al. Cryptococcus neoformans-Infected Macrophages Release Proinflammatory Extracellular Vesicles: Insight into Their Components by Multi-omics. [J]. mBio. 2021;12(2):e00279-21.
Á˽â¸ü¶à»ªÓ¯Êӽǽâ¶Á£¬»¶Ó¹Ø×¢“k8¿·¢(Öйú)”¹«ÖÚºÅ
µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã
µç»°£º400-869-2936£¬021-33968791
ÓÊÏ䣺support@wayenbiotech.com
´«Õ棺021-33938792
QQ£º2120485725
Õ½ÂÔºÏ×÷
Õ½ÂÔºÏ×÷
| Full Moon | RayBiotech | CDI | IZON | Bio-Rad | R&D Systems | IsoPlexis | ÄÏÄ£ÉúÎï | Å·Ò×ÉúÎï | ÆäÃ÷ÐÅÏ¢ | ÃÀ¼ªÉúÎï | ÂóÌØ»æÆ× |
Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿·¢(Öйú)Ô´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£